RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+21.69%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.03B
AUM Growth
+$2.03B
(+25%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
7.95%
Top 10 Holdings %
Top 10 Hldgs %
49.69%
Holding
77
New
15
Increased
27
Reduced
15
Closed
12
Top Buys
| 1 |
AstraZeneca
AZN
|
$76.1M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$64.1M |
| 3 |
Insmed
INSM
|
$61.8M |
| 4 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$52.1M |
| 5 |
AET
Aetna Inc
AET
|
$37.2M |
Top Sells
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$66.3M |
| 2 |
Elevance Health
ELV
|
$43.6M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$35M |
| 4 |
Penumbra
PEN
|
$33M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$30M |
Sector Composition
| 1 | Healthcare | 89.36% |
| 2 | Financials | 3.41% |
| 3 | Communication Services | 0.62% |
| 4 | Energy | 0.01% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $216M | 10.65% | 17,556,586 +1,462,800 | +9% | +$18M |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $166M | 8.19% | 11,012,561 -1,031,371 | -9% | -$15.6M |
|
3
Puma Biotechnology
PBYI
$254M
| $109M | 5.36% | 906,642 +46,186 | +5% | +$5.53M |
|
|
SGEN
4
DELISTED
Seagen Inc. Common Stock
SGEN
| $100M | 4.95% | 1,843,733 +1,178,594 | +177% | +$64.1M |
|
|
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
| $82.1M | 4.05% | 996,610 +232,221 | +30% | +$19.1M |
|
|
ALDR
6
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $79.3M | 3.91% | 6,476,766 +4,252,955 | +191% | +$52.1M |
|
|
7
AstraZeneca
AZN
$248B
| $76.1M | 3.75% | +2,246,300 | New | +$76.1M |
|
|
8
Insmed
INSM
$28.8B
| $62.2M | 3.07% | 1,991,646 +1,979,266 | +15,988% | +$61.8M |
|
|
IMGN
9
DELISTED
Immunogen Inc
IMGN
| $61.7M | 3.04% | 8,061,497 +2,848,761 | +55% | +$21.8M |
|
10
Regenxbio
RGNX
$451M
| $55M | 2.71% | 1,667,672 -50,999 | -3% | -$1.68M |
|
|
11
Penumbra
PEN
$10.6B
| $51.1M | 2.52% | 565,511 -365,933 | -39% | -$33M |
|
12
Wave Life Sciences
WVE
$1.53B
| $49.3M | 2.43% | 2,267,707 +43,300 | +2% | +$942K |
|
13
Atara Biotherapeutics
ATRA
$84.6M
| $47.8M | 2.36% | 2,889,710 +155,666 | +6% | +$2.58M |
|
14
LivaNova
LIVN
$3.08B
| $44.3M | 2.19% | 632,488 +420,460 | +198% | +$29.5M |
|
15
Centene
CNC
$14.3B
| $39.2M | 1.93% | 404,600 +6,400 | +2% | +$619K |
|
16
ICU Medical
ICUI
$3.15B
| $37.5M | 1.85% | 201,750 +69,245 | +52% | +$12.9M |
|
|
AET
17
DELISTED
Aetna Inc
AET
| $37.2M | 1.83% | +233,837 | New | +$37.2M |
|
|
BOLD
18
DELISTED
Audentes Therapeutics, Inc
BOLD
| $36.1M | 1.78% | 1,289,332 -170,284 | -12% | -$4.77M |
|
|
OXFD
19
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $34.5M | 1.7% | 2,051,487 -104,462 | -5% | -$1.75M |
|
|
GWPH
20
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $34.4M | 1.69% | 338,536 -106,400 | -24% | -$10.8M |
|
21
eHealth
EHTH
$118M
| $32M | 1.58% | 1,337,623 +114,289 | +9% | +$2.73M |
|
22
Molina Healthcare
MOH
$9.8B
| $31.7M | 1.56% | 461,074 -367,500 | -44% | -$25.3M |
|
|
PRAH
23
DELISTED
PRA Health Sciences, Inc.
PRAH
| $30.6M | 1.51% | +402,014 | New | +$30.6M |
|
|
ELGX
24
DELISTED
Endologix Inc
ELGX
| $29.2M | 1.44% | 6,544,676 +176,377 | +3% | +$787K |
|
|
NITE
25
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $28.8M | 1.42% | +1,769,346 | New | +$28.8M |
|